Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.
about
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Cytomegalovirus infection in immunocompetent critically ill adults: literature reviewDual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interfaceResistant pathogens, fungi, and viruses.Rapid discrimination of MHC class I and killer cell lectin-like receptor allele variants by high-resolution melt analysis.Reactivation of multiple viruses in patients with sepsis.Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss.Low prevalence of active cytomegalovirus infection in a cardiovascular intensive care unit.Sepsis and cytomegalovirus: foes or conspirators?Activation of human herpesvirus replication by apoptosisActivation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner.Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.Sepsis induced immunosuppression: Implications for secondary infections and complications.Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection.5(th) International Workshop on CMV and Immunosenescence - A shadow of cytomegalovirus infection on immunological memory.Editorial: Once more unto the breach, dear friends: CMV reactivates when the walls come down.Epidemiology and Immune Pathogenesis of Viral Sepsis
P2860
Q27692570-F60A9387-0C7C-4284-ADBA-DA5A779CE778Q28079509-9902D143-9926-466C-AA56-6231AE355CD0Q28533839-93E8588B-9CD1-4034-B8BB-077668D6E778Q30301237-2CD62FCE-E678-4875-A924-9CEA705CA2E6Q30417911-2782D9C0-4F61-4029-82B5-C39E4EAAFB35Q33740315-03D93500-16B8-4EA9-AFF9-6AB84301A0E0Q33828888-02690046-2F51-4922-804A-ABFA9C7FB456Q33833216-149D2AAC-6715-4840-B5C3-743F24F54AF0Q34711417-AF1D4613-238E-4BD5-BB93-1DE848F9E8F8Q37055722-22265526-E729-4998-9B43-E8B52CBD43C7Q37252864-4F86EAC1-A141-4763-B0A4-BBF8E5265C3CQ37254205-B9150046-21CD-4286-85B6-C118DB5A8566Q38053067-FD8D8990-88B6-42A3-833D-062EA0B5E2D3Q38148132-9CC2AA7C-C551-4018-9E8E-19E59572E13CQ38541110-DBD65E36-13E4-441A-A8AD-AB10FC8C4020Q40355419-23B6C698-F241-4DA3-8F9C-152A6A1186E4Q49115156-184516E2-7C08-4C2A-A447-CA42AE325E7FQ50930306-3377BA08-B0BD-4607-96AD-FE1C5496151CQ57490857-0F8B3F86-D5CB-45D2-804B-978FE8FE4794
P2860
Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@ast
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@en
type
label
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@ast
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@en
prefLabel
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@ast
Cytomegalovirus reactivation i ...... ress and remaining challenges.
@en
P2860
P1433
P1476
Cytomegalovirus reactivation i ...... gress and remaining challenges
@en
P2093
Joanne Trgovcich
P2860
P304
P356
10.1016/J.ANTIVIRAL.2011.03.179
P577
2011-03-23T00:00:00Z